Abstract
Objective
Patients with transfusion-dependent thalassemia (TDT) are at risk of developing pulmonary artery hypertension (PAH) due to chronic hemolysis, iron overload, hypercoagulability and splenectomy. The objective of the study was to assess the prevalence and predictors of PAH in patients with TDT.
Methods
Patients aged 6–18 years with TDT were included. 2D-echocardiography was done to measure the pulmonary artery systolic pressure (PASP) and left ventricular ejection fraction (LVEF). T2* MRI was done to evaluate cardiac iron overload. N-terminal-pro brain natriuretic peptide (NT-pro BNP) level was also assessed.
Results
Out of 60 participants, PAH was noted in 19 (31.6%). Mean (SD) age of the patients with PAH and without PAH was 12.2 (3.8) and 9.6 (3.5) years, respectively (P = 0.016). Five of 19 patients with PAH (26.3%) had undergone splenectomy as against 5 of 41 patients without PAH (12.2%) (P = 0.17). Years since splenectomy was higher in the PAH group. Mean (SD) NT-Pro BNP levels were also higher in patients with PAH [63.80 (25.89) vs 41.97 (23.95), P = 0.01]. Significantly higher number of patients with PAH had cardiac T2* value of < 10 ms (P = 0.04). Age (OR 4.11; 95% CI 1.46–8.77), years since splenectomy (OR 3.24; 95% CI 1.30–7.86), NT-Pro BNP levels (OR 4.43; 95% CI 2.14–9.60) and cardiac T2* MRI (OR 2.46; 95% CI 2.18–6.90) values were predictors of PAH in patients with TDT.
Conclusion
PAH was observed in 31.6 % of patients, with older age and years since splenectomy being important risk factors. NT-Pro BNP can be used as screening test for detecting PAH.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Machado RF, Gladwin MT. Pulmonary hypertension in hemolytic disorders: Pulmonary vascular disease: The global perspective. Chest. 2010;137:30S–8S.
Moghaddam HM, Badiei Z, Eftekhari K, Shakeri R, Farhangi H. Prevalence of pulmonary hypertension in patients with thalassemia intermedia in 2009: a single centre’s experience. Electron Physician. 2015;7:1102–7.
Khadilkar V, Yadav S, Agrawal KK, Tamboli S, Bannerjee M, Cherian A. Revised IAP growth charts for height, weight and body mass index for 5–18 year old Indian children. Indian Pediatr. 2015;52:47–55.
Tissot C, Muehlethaler V, Serarski N. Basics of functional echocardiography in children and neonates. Front Pediatr. 2017; 5: 235–9.
Gupta V, Kumar I, Raj V, Aggarwal P, Agrawal V. Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion dependent thalassemia: a randomized double-blind placebo-controlled trial, Pediatr Blood Cancer. 2022;69: e29564.
Atichartakarn V, Chuncharunee S, Archararit N, et al. Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/β-thalassemia disease. Eur J Haematol. 2013;92:346–53.
Vlahos AP, Koutsouka FP, Papamichael ND, et al. Determinants of pulmonary hypertension in patients with beta-thalassemia major and normal ventricular function. Acta Haematol. 2012;128:124–9.
Aessopos A, Farmakis D, Trompoukis C, et al. Cardiac involvement in sickle beta-thalassemia. Ann Hematol. 2009; 88:557–64.
Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997;134:532–7.
Atichartakarn V, Likittanasombat K, Chuncharunee S, et al. Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders. Int J Hematol. 2003;78:139–45.
Voskoridou E, Tsetsos G, Tsoutsias A, Spyropoulou E, Christoulas D, Terpos E. Pulmonary hypertension in patients with sickle cell/β thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica. 2007;92:738–43.
Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-pro BNP in clinical routine. Heart. 2006; 92:843–9.
Aessopos A, Farmakis D, Hatziliami A, et al. Cardiac status in well-treated patients with thalassemia major. Eur J Haematol. 2004;73: 359–66.
Meloni A, Detterich J, Pepe A, Harmatz P, Coates TD, Wood JC. Pulmonary hypertension in well-transfused thalassemia major patients. Blood Cells Mol Dis. 2015; 54: 189–94.
Funding
Funding: None
Author information
Authors and Affiliations
Contributions
Contributors: VG conceptualized and wrote the article. VV and PA collected the data, IK analyzed the MRI results, VA helped in cardiac evaluation. All authors approved the final manuscript and are accountable.
Corresponding author
Ethics declarations
Ethic clearance: Dean/2019/EC/1756 dated 18.11.2019.
Competing interests: None stated.
Rights and permissions
About this article
Cite this article
Gupta, V., Vijayakumar, V., Aggarwal, P. et al. Pulmonary Artery Hypertension in Transfusion-Dependent Thalassemia. Indian Pediatr 61, 49–52 (2024). https://doi.org/10.1007/s13312-024-3087-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-024-3087-2